Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector




















Sort by: Date|Relevance

Biogen Shares Rebound Strongly on Updated Phase 3 Alzheimer's Data and Q3 Earnings

Shares of Biogen Inc. opened nearly 39% higher today after the firm announced plans to submit a Biologics License Application to the FDA in early 2020 for its Alzheimer's drug aducanumab based on new analysis of larger datasets from two phase 3 studies. The company also anno...

The Buzz About this New Green Agri-Tech Investment

Imagine a world where crop yields are always thriving. Imagine a world where disease and pests are managed with a completely natural innovative solution. Imagine a world where a nature takes care of healthy, thriving crops. Well, that world and those solutions are not as fa...

Gold Likes the IMF Predicting a Deeper Recession

IMF predicts deeper global recession and slower recovery, just as I expected. Good news for gold. The June edition of the IMF’s World Economic Outlook Report Update is out! The main message is that the IMF predicts now even a deeper recession than t...

NurExone Biologic announces important test results

By Brad Sorensen, CFA, Zacks Research. NurExone Biologic (TSXV:NRX; OTCQB:NRXBF) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries, while also conducting preclinical tests for other conditions that ExoPTEN m...

Dec 6th 2019, Crypto Chartbook – Staying alert in pat

Staying alert in pat We advocate a contrarian approach based on a time frame confluence system. When this confluence is absent as of right now, we do not open new large size positions. Most of the times we are positioned already and take possibly some reloads. The followin...

Dec 12th 2019, Silver Chartbook – Aggressive participation, why?

Aggressive participation, why? As much as we use a technical analysis dominated approach toward the markets, it would be foolish to not have those views guided by fundamentals. It is at this point in time a true confluence point of world wide events that drive o...

Capitalizing on Plunging Oil as Iran Tensions Subside

Yesterday, we wrote: (…) Although crude oil futures moved higher after Wednesday’s open and broke above the previous peaks, this improvement was very temporary, and the bears took over in the following hours. As a result, the futures came back belo...

Coronavirus Strikes Back. But Force Is Strong With Gold

We all fear the second wave of infections. But the U.S. hasn’t even controlled the first one! Bad news for Americans, but good news for gold. Please take a look at the chart below. As you can see, the epidemiological situation in the United States d...

Buzz on the Bullboards: Navigating volatility

The TSX and the TSX Venture Exchange have faced significant turbulence this week after a major global sell-off, an unexpected development given the TSX’s recent all-time high. This stark contrast points to the current market volatility, reminding investors...

The Repatriators

The Europeans want their gold back. Amid global trade uncertainty, a pall hanging over the European Union due to continued economic weakness , the exit of Great Britain still a real possibility, and dark, nationalist undercurrents swirling, several of the 28-strong EU mem...
1 2 3 4 5 6 7